Arcus Biosciences, Inc. (RCUS)

23.11 +0.40 (+1.76%) USD  |  NYSE  |  Dec 24, 12:59
23.11 0.00 (0.00%) After-Hours: 13:59
More

Arcus Biosciences SG&A Expense (TTM): 112.00M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. 5.886B
Actinium Pharmaceuticals, Inc. 15.79M
Apyx Medical Corp. 22.16M
Merck & Co., Inc. 10.70B
Karyopharm Therapeutics, Inc. 109.63M